The largest database of trusted experimental protocols

Ensure liquid

Manufactured by Abbott
Sourced in Japan

Ensure Liquid® is a complete, balanced, nutritional supplement that provides essential nutrients to support overall health and wellness. Its core function is to deliver a range of essential vitamins, minerals, and high-quality protein to individuals who may have difficulty meeting their nutritional needs through diet alone.

Automatically generated - may contain errors

4 protocols using ensure liquid

1

Quantitative Analysis of CBZ

Check if the same lab product or an alternative is used in the 5 most similar protocols
CBZ was purchased from FUJIFILM Wako Pure Chemical Co., Ltd. (Tokyo, Japan). Flunitrazepam, as the internal standard, was purchased from Sigma-Aldrich (Tokyo, Japan). Tegretol® powder (2-fold dilution in the presence of a vehicle; Mitsubishi Tanabe Pharma Corporation, Osaka, Japan), F2α® (TERUMO Co. Ltd., Tokyo, Japan), Racol® NF (Otsuka Pharmaceutical Factory, Inc., Tokyo, Japan), Ensure Liquid® (Abbott Japan Co. Ltd., Tokyo, Japan), and Renalen® LP (Meiji Seika Pharma Co., Ltd., Tokyo, Japan) were purchased from commercial sources. For animal anesthesia, sevoflurane was purchased from FUJIFILM Wako Pure Chemical Co., Ltd. Acetonitrile (Nacalai Tesque, Inc., Kyoto, Japan) was of chromatographic reagent grade, and the other chemicals were of analytical reagent grade.
+ Open protocol
+ Expand
2

Perioperative Feeding Regimen for Esophageal Surgery

Check if the same lab product or an alternative is used in the 5 most similar protocols
Patients began to drink clean water on POD 1 while the nasogastric tube was still in place. On POD 5 to 7, the nasogastric tube was removed and an oral diet was begun with soft and smooth food if the absence of AL and delayed gastric emptying was confirmed by a contrast swallow test. Furthermore, the chest tubes were removed at a threshold of 300 mL/day after the absence of atelectasis was confirmed on a radiograph. For patients with chyle leakage, the tubes were removed if the effluent rate continued to be ≤50 mL/day.
Enteral tube feeding via jejunostomy was started on POD 1 except when contraindications such as ileus were present. The patients in the low-fat group initiated treatment with a low fat-containing enteral feeding formula (ELENTAL®; Ajinomoto Pharmaceuticals Co., Ltd., Tokyo, Japan) continually until removal of the chest tubes (at least 7 days). The nutritional regimen in the present study was similar to that in a study by Moro et al.1 (link) The patients in the control group started treatment with an enteral diet with a standard fat-containing polymeric formula (ENSURE LIQUID®; Abbott Japan Co., Ltd., Tokyo, Japan). The median maximal amount of feeding administered to these patients ranged from 1,500 to 2,000 mL/day and 30 to 35 kcal/kg of body weight per day.
+ Open protocol
+ Expand
3

Enhanced Postoperative Recovery Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
On POD 1, patients were encouraged to get out of bed for more than 6 h. On POD 2, the oral intake was started with water and a can of oral nutrition supplement (250 ml Ensure Liquid ® , Abbott Japan Co., Ltd., Tokyo, Japan). The patients were encouraged to walk the length of the ward from POD 2. An antithrombotic agent (enoxaparin sodium 2000 IU twice daily or fondaparinux 2.5 mg daily) was injected for 2 days at 6 h after the removal of the epidural catheter. On POD 3, the patients started to eat soft food and graduated stepwise to regular food every 2 days (over three steps). The patients were discharged when they had achieved adequate pain relief and soft food intake, had returned to their preoperative mobility level, and exhibited normal laboratory data on POD 7.
+ Open protocol
+ Expand
4

Phosphorus Adsorbents in Renal Impairment

Check if the same lab product or an alternative is used in the 5 most similar protocols
We used phosphorus adsorbents listed in the National Health Insurance drug price standard as of March 2022 (Table 1). Enteral nutrition was supplied by Ensure Liquid ® (Lot No.: 608710; Abbott Japan LLC, Tokyo), and sterile water for injection (Lot No.: K207M; Otsuka Pharmaceutical Co., Ltd., Tokyo) was used for flushing.
Ensure Liquid ® was selected because it is the only medical enteral formula that is not contraindicated for patients with severe renal impairment and is covered by insurance. It is also the most commonly used medical enteral formula at Fujioka General Hospital.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!